Quantum biochemistry description of PI3Kα enzyme bound to selective inhibitors

Francisca Joseli Freitas de Sousa1, Francisca Fernanda Nunes Azevedo1, Francisco Lucas Santos de Oliveira2

  • 1Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Brazil.

Insights

This study investigated how selective inhibitors bind to PI3Kα, a key cancer target. Understanding these molecular interactions aids in designing more effective cancer drugs by identifying crucial binding hotspots.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Chemistry

Background:

  • Phosphoinositide 3-kinase (PI3K) class I enzymes regulate vital cellular processes.
  • Hyperactivation of PI3Kα is implicated in various cancers, driving poor prognosis.
  • Developing selective PI3K isoform inhibitors is challenging due to conserved ATP-binding pockets.

Purpose of the Study:

  • To investigate the molecular features governing the binding of alpelisib and GDC-0326 to the PI3Kα ATP-binding pocket.
  • To identify key amino acid residues and interactions critical for selective inhibitor binding.
  • To provide insights for the rational design of novel PI3Kα-targeting agents.

Main Methods:

  • Molecular dynamics simulations to relax protein structures.
  • Quantum calculations using the Molecular Fractionation with Conjugated Caps scheme and Density Functional Theory (DFT).
  • Calculation of atomic charges for ligands in bound and unbound states.

Main Results:

  • Identified key residues for alpelisib binding: Ile932, Glu859, Val851, Val850, Tyr836, Met922, Ile800, and Ile848.
  • Identified key residues for GDC-0326 binding: Ile848, Ile800, Ile932, Gln859, Glu849, and Met922.
  • Highlighted common hotspot residues (Trp780, Ile800, Tyr836, Ile848, Gln859, Val850, Val851, Ile932, Met922) for both inhibitors.

Conclusions:

  • The study elucidates molecular mechanisms underlying PI3Kα inhibitor selectivity.
  • Identified critical interactions that can guide the rational design of new, selective PI3K inhibitors.
  • Contributes to the development of more effective targeted cancer therapies.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.7K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.2K